Global Blood Transfusion Market - Segmented by Product, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)

  • ID: 4520154
  • Report
  • Region: Global
  • 112 pages
  • Mordor Intelligence
1 of 4

FEATURED COMPANIES

  • ABBOTT
  • B. BRAUN MELSUNGEN AG
  • BECTON DICKINSON
  • FRESENIUS KABI AG
  • HAEMONETICS CORPORATION
  • IMMUCOR
  • MORE
The global blood transfusion market is expected to witness a CAGR of 4.9% during the forecast period (2018-2023). The market is growing at a fast pace with the rise in accidental cases, the growing number of blood transfusion procedures, competition, and M&A activities.

Rising Accidents and Trauma Cases

Trauma is considered to be the foremost cause of death and approximately 1, 80,000 people die with trauma every year. Up to 45% of the polytrauma patients die as a result of circulatory shock from acute blood loss. The World Health Organization states that the burden of the diseases related to injuries are mostly the road traffic injuries, accidents, etc., and these accidents are expected to rise dramatically by the year 2020. Each year 1.25 million people die because of these road accidents and a large amount of blood is being lost which requires blood transfusion and ultimately leads to the growth of the market.

The other factors including the automation in blood processing equipment, the increase in the R&D initiatives for regenerative medicine, the increasing number of surgical procedures, and the rise in the number of blood disorders are also contributing to the growth of the market.

High Costs Associated with Handling of Blood

The blood supply for the transfusions is very limited as not only is the donor pool shrinking due to the aging population but also due to the stringent donor selection process, and this has ultimately increased the demand for blood transfusion. According to the American Association of Blood Banks, around 15 million units of the packed red blood cells are being transfused in the US, and around 85 million units are being transfused annually worldwide. Currently 1% of total hospital costs are attributed to blood transfusion, however, this may vary by disease and procedures. The high costs associated with the blood transfusion have restricted the growth of the blood transfusion market.

The other factors include stringent rules and regulations, like approvals needed for separation of blood components, limit the total number of end-users, thereby, reducing the market size.

North America Dominates the Market

Geographically, North America is expected to dominate the market, owing to its well-developed healthcare industry and a rise in the number of patient’s population requiring the blood. However, the Asia-Pacific region is also projected to grow at the highest growth rate due to the rising government initiatives for the improvement of the healthcare facilities and increase in the number of blood banks.

Major Players: ABBOTT, MACOPHARMA, BECTON DICKINSON, B. BRAUN MELSUNGEN AG, TERUMO MEDICAL CORPORATION, HAEMONETICS CORPORATION, FRESENIUS KABI AG, IMMUCOR, AND KIDDE-FENWAL INC., amongst others.

Reasons to Purchase this Report
  • Current and future global blood transfusion market outlook in the developed and emerging markets
  • Various perspectives of the market, with the help of Porter’s five forces analysis
  • The segment expected to dominate the market
  • The region expected to witness the fastest growth rate during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players
  • 3 months analyst support, along with the Market Estimate sheet (in Excel)
Customization of the Report

This report can be customized to meet your requirements.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • ABBOTT
  • B. BRAUN MELSUNGEN AG
  • BECTON DICKINSON
  • FRESENIUS KABI AG
  • HAEMONETICS CORPORATION
  • IMMUCOR
  • MORE
1. Introduction
1.1 Market Definition

2. Research Methodology

3. Executive Summary

4. Key Inferences

5. Market Overview
5.1 Current Market Scenario
5.2 Porter's Five Forces Analysis
5.2.1 Bargaining Power of Suppliers
5.2.2 Bargaining Power of Consumers
5.2.3 Threats of New Entrants
5.2.4 Threat of Substitute Product and Services
5.2.5 Competitive Rivalry Within the Industry

6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rising Accidents and Trauma Cases
6.1.2 Increasing Number of Surgical Procedures
6.1.3 Increase in R&D Initiatives for Regenerative Medicine
6.1.4 Automation in Blood Processing Equipment
6.1.5 Rise in the Number of Blood Disorders
6.2 Market Restraints
6.2.1 High Costs Associated with Handling of Blood and its Components
6.2.2 Strict Approval Process and Regulations
6.3 Opportunities
6.4 Key challenges

7. Market Segmentation
7.1 -By Product
7.1.1 Blood Bag and Accessory
7.1.2 Blood Mixer
7.1.3 Fridge and Freezer
7.1.4 Filter
7.1.4.1 Inline Filter
7.1.4.2 Dockable Filter
7.1.5 Blood Component Separator
7.1.6 Apheresis Device
7.1.7 Pathogen Reduction System
7.1.8 Consumables and Supplies
7.1.9 Others
7.2 -By End User
7.2.1 Hospital
7.2.2 Ambulatory Surgical Centers
7.2.3 Blood Bank
7.2.4 Laboratory
7.2.5 Others
7.3 -By Geography
7.3.1 North America
7.3.1.1 United states
7.3.1.2 Canada
7.3.1.3 Mexico
7.3.2 Europe
7.3.2.1 France
7.3.2.2 Germany
7.3.2.3 United kingdom
7.3.2.4 Italy
7.3.2.5 Spain
7.3.2.6 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 Japan
7.3.3.3 India
7.3.3.4 Australia & New Zealand
7.3.3.5 South Korea
7.3.3.6 Rest of Asia-Pacific
7.3.4 Middle East & Africa
7.3.4.1 GCC
7.3.4.2 South Africa
7.3.4.3 Rest of the Middle East & Africa
7.3.5 South America
7.3.5.1 Brazil
7.3.5.2 Argentina
7.3.5.3 Rest of South America

8. Competitive Landscape
8.1 Mergers & Acquisition Analysis
8.2 Agreements, Collaborations, and Partnerships
8.3 New Products Launches

9. Key Players
9.1 Abbott
9.2 Macopharma
9.3 Becton Dickinson
9.4 B. Braun Melsungen AG
9.5 Terumo Medical Corporation
9.6 Haemonetics Corporation
9.7 Fresenius Kabi AG
9.8 Immucor
9.9 Kidde-Fenwal Inc.
9.10 Others
9.11 List not Exhaustive

10. Future of the Market
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • ABBOTT
  • MACOPHARMA
  • BECTON DICKINSON
  • B. BRAUN MELSUNGEN AG
  • TERUMO MEDICAL CORPORATION
  • HAEMONETICS CORPORATION
  • FRESENIUS KABI AG
  • IMMUCOR
  • KIDDE-FENWAL INC.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll